P1474: HEMOLYTIC MARKERS, MORTALITY, AND THROMBOEMBOLIC EVENTS IN CAD: RISK ASSESSMENT BY TIME PERIOD SINCE DIAGNOSIS

• Quentin A Hill,
• Wilma Barcellini,
• Alexander Röth,
• Alia Karaouni,
• Marion Afonso,
• Yoo Ronnie,
• Julien Tanniou,
• Julien Rubio,
• Catherine M Broome

Affiliations

Quentin A Hill

1 Leeds Teaching Hospitals NHS Trust, Department of Clinical Hematology, Leeds, United Kingdom

Wilma Barcellini

2 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Hematology Unit, Milan, Italy

Alexander Röth

3 West German Cancer Center, University Hospital Essen, Department of Hematology and Stem Cell Transplantation, Essen, Germany

Alia Karaouni

4 BMAPS SARL, Geneva, Switzerland

Marion Afonso

5 Sanofi, Chilly-Mazarin Cedex, France

Yoo Ronnie

6 Sanofi, Massachusetts, United States

Julien Tanniou

7 Quinten Health, Paris, France

Julien Rubio

7 Quinten Health, Paris, France

Catherine M Broome

8 MedStar Georgetown University Hospital, Division of Hematology, Washington, United States